Data Regarding Abraxane, Gemcitabine Plus Nivolumab Combo Study In Pancreatic Cancer
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At UCLA Discusses Data Regarding Abraxane,...
Author: obr
Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts
Gemcitabine + Abraxane - Standard for Pancreatic Cancer | Investigational Agents - Nivolumab-Anti-PD1 & Anti-CD40
Ramy Ibrahim, M.D., Parker Institute for Cancer Immunotherapy, explains the combination of Gemcitabine + Abraxane - Standard for Pancreatic Cancer | Investigational Agents - Nivolumab-Anti-PD1 & Anti...
Author: Cancer-News
Added: 07/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Nab-Paclitaxel and Abraxane - Dr. Wendy Lam
This video will explore the role of Abraxane in the treatment of metastatic melanoma patients, review of recent research on the clinical use of Nab-Paclitaxel in British Columbia in Metastatic Breast ...
Author: oncologyeducation
Added: 09/05/2013 (Source: Oncology Tube)
Source: Oncology Tube - September 5, 2013 Category: Cancer & Oncology Source Type: podcasts
